sim1803-1a

Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion

Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 1

—

Rating in progress

sim1803-1a in Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant